TUSTIN, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization […]
– COVID-19 program in preclinical development; Discussions with potential strategic partners ongoing –– Merck collaboration to discover and develop influenza […]
Biogen to receive license to co-develop and co-commercialize Denali’s small molecule LRRK2 inhibitor program, expanding pipeline of potential therapies in […]